LUCY
LUCY
NASDAQ · Health Care

Innovative Eyewear Inc

$0.81
+0.00 (+0.21%)
As of Nov 14, 2:49 AM ET ·
Financial Highlights (FY 2026)
Revenue
5.81M
Net Income
-16,568,110
Gross Margin
21.3%
Profit Margin
-285.2%
Rev Growth
+59.2%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 21.3% 21.3% 62.7% 62.7%
Operating Margin -319.2% -287.2% 15.5% 16.4%
Profit Margin -285.2% -270.9% 9.6% 11.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.81M 3.65M 2.98M 2.71M
Gross Profit 1.24M 778.1K 1.87M 1.70M
Operating Income -18,541,076 -10,483,739 461.5K 445.9K
Net Income -16,568,110 -9,368,159 285.3K 317.3K
Gross Margin 21.3% 21.3% 62.7% 62.7%
Operating Margin -319.2% -287.2% 15.5% 16.4%
Profit Margin -285.2% -270.9% 9.6% 11.7%
Rev Growth +59.2% +59.2% +8.5% -7.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.44M 1.22M
Total Equity — — 3.52M 3.66M
D/E Ratio — — 0.41 0.33
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,395,071 -10,979,027 526.6K 581.1K
Free Cash Flow — — 264.2K 181.0K